Our specific aim was to evaluate glymphatic system abnormalities in presymptomatic and symptomatic individuals with pathogenic mutations within the MAPT, GRN and C9orf72 genes, to provide novel insight into the pathophysiology of genetic frontotemporal dementia. This evidence concerns the gene GRN and frontotemporal dementia.